GO:0032935 sterol sensor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032935 sterol sensor activity is a molecular function defined as binding to and responding to changes in cellular sterol levels, often through conformational change.
• The sterol-sensing domain (SSD) is a conserved protein module that detects cholesterol and related sterols in membranes.
• Key sterol sensor proteins include SCAP, NPC1, HMGCR, and Patched, which regulate lipid metabolism, immune signaling, and development.
• Dysregulated sterol sensing contributes to cancer, neurodegeneration, and metabolic disorders.
• CRISPR knockout, point mutation, and knock-in models are essential to dissect sterol sensor function.
• EDITGENE provides custom cell models and screening services to study sterol sensor activity in disease contexts.
Description
Sterol sensor activity (GO:0032935) is a molecular function that enables a protein to bind sterols and respond to changes in their cellular concentration, typically via conformational changes. This activity is critical for maintaining lipid homeostasis and is mediated by conserved sterol-sensing domains (SSDs) found in proteins such as SCAP, NPC1, and HMGCR. Researchers study this term to understand how cells sense cholesterol and oxysterols, and how dysfunction leads to diseases like cancer and neurodegeneration. The importance of sterol sensing extends to immune regulation, where cholesterol accumulation drives T cell exhaustion, and to inflammasome control by oxysterols. Thus, GO:0032935 represents a central node in lipid biology with broad physiological and pathological implications.
sterol sensor activity At A Glance
| GO ID | GO:0032935 |
|---|---|
| GO term | sterol sensor activity |
| Ontology | molecular_function |
| Synonym | sterol sensing activity, sterol-sensing domain |
| Major function | Binding to sterols and responding to changes in cellular sterol levels |
| Definition | Binding to and responding, e.g. by conformational change, to changes in the cellular level of a sterol. |
| Related proteins | SCAP, NPC1, HMGCR, Patched, INSIG1/2 |
| Disease relevance | Cancer, neurodegeneration, metabolic disorders, immune dysfunction |
What Is GO:0032935?
According to QuickGO, sterol sensor activity (GO:0032935) is the binding to and responding, e.g. by conformational change, to changes in the cellular level of a sterol. This function is often associated with sterol-sensing domains (SSDs) that undergo structural rearrangements upon sterol binding, thereby transmitting signals to downstream effectors.
Why Is sterol sensor activity Important in Cell Biology?
Sterol sensor activity is fundamental to cellular lipid homeostasis and signaling. Proteins with sterol-sensing domains, such as SCAP and NPC1, regulate cholesterol synthesis, uptake, and trafficking. Dysregulation of these sensors is linked to cancer progression, where cholesterol accumulation promotes immune evasion, and to neurodegenerative diseases like Alzheimer's, where cholesterol mishandling drives senescence. Understanding GO:0032935 provides insights into therapeutic targets for metabolic and immune disorders.
• Regulates cholesterol synthesis via SREBP pathway through SCAP/Insig.
• Controls inflammasome activation by oxysterols, linking sterol sensing to innate immunity.
• Mediates STING signaling and Niemann-Pick disease type C pathology.
• Cholesterol accumulation induces CD8+ T cell exhaustion in tumors.
• Implicated in Alzheimer's disease through APOE4 and ABCA1-mediated senescence.
• Modulates phosphoinositide and cholesterol regulation of STING.
• Potential target for cancer therapy via lipid metabolism reprogramming.
• Involved in metformin effects on adipose tissue browning.
• Essential for developmental processes via Patched and Hedgehog signaling.
• Provides a model for studying membrane protein conformational changes.
Core Biology of sterol sensor activity
Sterol Binding and Conformational Change
In simple terms: When cholesterol levels change, sensor proteins change shape to send signals.
Sterol sensor proteins contain a sterol-sensing domain (SSD) that binds cholesterol or oxysterols. Binding induces conformational changes that alter interactions with partner proteins, such as SCAP with Insig. This structural switch is critical for downstream signaling, as seen in SCAP/Insig dissociation upon ammonia stimulation.
Regulation of SREBP Pathway
In simple terms: Sterol sensors control the master switch for making cholesterol.
SCAP senses cholesterol and regulates SREBP activation. When sterols are low, SCAP escorts SREBP to the Golgi for processing; when sterols are high, Insig binds SCAP and retains it in the ER. This feedback loop is essential for lipid homeostasis and is hijacked in cancer.
Sterol Sensing in Immune Signaling
In simple terms: Sterol sensors help immune cells respond to danger signals.
Oxysterols restrain cholesterol synthesis and prevent AIM2 inflammasome activation. Cholesterol also induces CD8+ T cell exhaustion in the tumor microenvironment. STING signaling is regulated by phosphoinositide and cholesterol, implicating sterol sensors in innate immunity.
Lysosomal Sterol Sensing and Trafficking
In simple terms: Sensors in lysosomes manage cholesterol transport and recycling.
NPC1 is a sterol sensor in the lysosomal membrane that mediates cholesterol egress. Mutations cause Niemann-Pick disease type C, with tonic prime-boost of STING signaling. Lysosomal ABCA1 in APOE4 carriers links cholesterol accumulation to cellular senescence in Alzheimer's disease.
Sterol Sensing in Development and Adipose Tissue
In simple terms: Sterol sensors guide tissue development and fat metabolism.
Patched, a sterol sensor, regulates Hedgehog signaling during development. Metformin prevents pathological browning of subcutaneous white adipose tissue, potentially through sterol-sensing pathways. These roles highlight the broad impact of GO:0032935.
Key Genes Involved in GO:0032935 sterol sensor activity
The following genes encode proteins with sterol sensor activity or are directly involved in sterol sensing pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SCAP | Senses cholesterol and regulates SREBP activation | Central to lipid metabolism and cancer |
| INSIG1 | Binds SCAP and retains it in ER when sterols high | Negative regulator of SREBP |
| INSIG2 | Similar to INSIG1, regulates SREBP | Feedback control of cholesterol synthesis |
| HMGCR | Sterol sensor and rate-limiting enzyme in cholesterol synthesis | Target of statins; degraded upon sterol binding |
| NPC1 | Lysosomal sterol sensor for cholesterol egress | Mutations cause Niemann-Pick type C |
| NPC2 | Cholesterol binding protein in lysosome | Works with NPC1 in cholesterol trafficking |
| PTCH1 | Sterol sensor in Hedgehog signaling | Developmental disorders and cancer |
| ABCA1 | Cholesterol efflux pump with sterol-sensing domain | Linked to APOE4 and Alzheimer's senescence |
| STING1 | Regulated by cholesterol and phosphoinositides | Innate immunity and Niemann-Pick disease |
| AIM2 | Inflammasome sensor restrained by oxysterols | Innate immunity and inflammation |
| SREBF1 | Transcription factor activated by SCAP | Lipogenesis and tumor growth |
| SREBF2 | Transcription factor for cholesterol synthesis | Feedback regulation |
| APOE | Lipoprotein involved in cholesterol transport | Alzheimer's disease risk |
| CYP46A1 | Cholesterol 24-hydroxylase producing oxysterols | Brain cholesterol metabolism |
| CH25H | Produces 25-hydroxycholesterol | Immune regulation |
| SQLE | Squalene epoxidase in cholesterol synthesis | Target in cancer |
| LDLR | LDL receptor regulated by SREBP | Cholesterol uptake |
How Is sterol sensor activity Regulated?
Sterol sensor activity is regulated by cellular sterol levels, which control conformational changes and protein-protein interactions. For example, SCAP undergoes a conformational change upon cholesterol binding, leading to Insig dissociation and SREBP activation. Ammonia stimulates SCAP/Insig dissociation, promoting lipogenesis and tumor growth. Oxysterols can restrain cholesterol synthesis and prevent inflammasome activation. Additionally, phosphoinositides and cholesterol regulate STING activation. These regulatory mechanisms ensure tight control of lipid homeostasis.
sterol sensor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCAP | Cancer (lipogenesis, tumor growth) | Knockout in cancer cell lines |
| NPC1 | Niemann-Pick disease type C | Patient-derived fibroblasts or KO iPSCs |
| APOE | Alzheimer's disease | APOE4 knock-in mice or iPSCs |
| STING1 | Innate immunity, Niemann-Pick disease | KO and point mutation models |
| AIM2 | Inflammasome-related inflammation | Oxysterol treatment in KO macrophages |
Cancer and Lipid Metabolism Reprogramming
Sterol sensor activity is hijacked in cancer to support rapid growth. SCAP/Insig dissociation by ammonia promotes SREBP-1 activation and lipogenesis, driving tumor growth. Cholesterol accumulation induces CD8+ T cell exhaustion, impairing anti-tumor immunity. Lipid metabolism reprogramming is a hallmark of cancer, with potential targets like SCAP and SREBP.
Neurodegeneration and Lysosomal Storage Disorders
NPC1 mutations cause Niemann-Pick disease type C, characterized by lysosomal cholesterol accumulation and STING signaling dysregulation. In Alzheimer's disease, APOE4 and lysosomal ABCA1 mediate cholesterol accumulation-induced senescence. These findings link sterol sensor dysfunction to neurodegeneration.
Innate Immunity and Inflammasome Regulation
Oxysterols restrain cholesterol synthesis and prevent AIM2 inflammasome activation, highlighting sterol sensors in inflammation. STING activation is regulated by cholesterol and phosphoinositides, affecting immune responses. Cholesterol-induced T cell exhaustion further underscores immune modulation by sterol sensing.
From sterol sensor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SCAP sterol sensing regulate tumor growth? | SCAP knockout cancer cell lines |
| How does NPC1 mutation affect STING signaling? | NPC1 KO or point mutation cells |
| What is the role of APOE4 in cholesterol-induced senescence? | APOE4 knock-in iPSCs |
| Can oxysterols inhibit AIM2 inflammasome? | AIM2 KO macrophages treated with oxysterols |
| How does cholesterol regulate STING? | STING point mutants in KO cells |
| Does metformin affect sterol sensing in adipose tissue? | Adipocyte-specific KO models |
How to Study the sterol sensor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality for sterol sensing | Identify novel regulators |
| Cholesterol pull-down | Direct sterol-protein binding | Validate SSD binding |
| FRET conformational sensor | Conformational changes upon sterol binding | Real-time sensing |
| Filipin staining | Cellular cholesterol distribution | Lysosomal accumulation |
| RNA-seq | Transcriptional changes | SREBP target gene expression |
| Lipidomics | Lipid species quantification | Cholesterol and oxysterol levels |
| Immunoblotting | Protein cleavage and stability | SREBP processing |
| STING signaling assay | Cytokine production | Innate immune activation |
CRISPR Knockout Screens
Genome-wide CRISPR knockout screens can identify genes required for sterol sensing, such as SCAP and NPC1. These screens use cholesterol deprivation or oxysterol treatment to select for resistant or sensitive clones.
Biochemical Assays for Sterol Binding
Sterol binding can be measured using photoaffinity labeling, isothermal titration calorimetry, or cholesterol pull-down assays. Conformational changes are detected by limited proteolysis or FRET.
Imaging and Trafficking Studies
Fluorescent cholesterol analogs (e.g., filipin) and GFP-tagged sensors allow visualization of sterol distribution and trafficking in live cells. Lysosomal cholesterol accumulation in NPC1 mutants is a classic readout.
Transcriptomics and Lipidomics
RNA-seq and lipidomics reveal global changes in gene expression and lipid species upon sterol sensor perturbation. SREBP target genes are key markers.
How CRISPR Can Be Used to Study GO:0032935 sterol sensor activity
Knockout
CRISPR knockout of sterol sensor genes (e.g., SCAP, NPC1) abolishes sterol sensing, leading to constitutive SREBP activation or cholesterol accumulation. These models are used to study downstream effects on lipid metabolism and disease.
Point Mutation
Point mutations in the sterol-sensing domain (e.g., SCAP Y298C) can lock the protein in active or inactive conformations, allowing precise dissection of sterol binding versus signaling.
Knock-in
Knock-in of disease-associated mutations (e.g., NPC1 I1061T) recreates patient phenotypes in cell models, enabling drug screening and mechanistic studies.
Overexpression
Overexpression of wild-type or mutant sterol sensors (e.g., SCAP, STING) amplifies signaling and can be used to study gain-of-function effects in lipid and immune pathways.
How EDITGENE Supports sterol sensor activity Research
Researchers studying sterol sensor activity-related genes often need to determine whether a candidate gene is causally involved in lipid sensing, immune regulation, or disease progression. EDITGENE provides custom CRISPR cell models and screening services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for sterol sensor activity research.
Frequently Asked Questions About sterol sensor activity
What is sterol sensor activity?
Sterol sensor activity (GO:0032935) is a molecular function where a protein binds sterols and responds to changes in cellular sterol levels, often by changing shape.
What genes are involved in sterol sensor activity?
Key genes include SCAP, INSIG1, INSIG2, HMGCR, NPC1, NPC2, PTCH1, ABCA1, and STING1.
What is the sterol-sensing domain?
The sterol-sensing domain (SSD) is a conserved protein module that binds cholesterol and undergoes conformational changes to regulate signaling.
How does sterol sensing regulate cholesterol synthesis?
SCAP senses cholesterol and controls SREBP activation; when sterols are high, Insig binds SCAP and retains it in the ER, blocking SREBP processing.
What diseases are linked to sterol sensor dysfunction?
Cancer, Niemann-Pick disease type C, Alzheimer's disease, and inflammatory disorders are linked to defective sterol sensing.
How can I study sterol sensor activity in the lab?
Use CRISPR knockout, point mutation, knock-in, and overexpression models combined with cholesterol binding assays, imaging, and transcriptomics.
What is the role of NPC1 in sterol sensing?
NPC1 is a lysosomal sterol sensor that mediates cholesterol egress; mutations cause Niemann-Pick disease type C.
Does cholesterol affect immune cells?
Yes, cholesterol accumulation induces CD8+ T cell exhaustion in the tumor microenvironment.
How do oxysterols regulate inflammasomes?
Oxysterols restrain cholesterol synthesis and prevent AIM2 inflammasome activation.
What CRISPR services does EDITGENE offer for sterol sensor research?
EDITGENE provides knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics for sterol sensor genes.
Conclusion
Sterol sensor activity (GO:0032935) is a critical molecular function that governs lipid homeostasis, immune signaling, and disease. Understanding its mechanisms through CRISPR models and biochemical assays can reveal new therapeutic targets. EDITGENE offers comprehensive services to accelerate research in this field.
References
- 1. Cheng C et al.. 2018. Lipid metabolism reprogramming and its potential targets in cancer.. Cancer Commun (Lond) 38(1):27 PMID: 29784041
- 2. Ma X et al.. 2019. Cholesterol Induces CD8(+) T Cell Exhaustion in the Tumor Microenvironment.. Cell Metab 30(1):143-156.e5 PMID: 31031094
- 3. Auger C et al.. 2019. Metformin prevents the pathological browning of subcutaneous white adipose tissue.. Mol Metab 29:12-23 PMID: 31668383
- 4. Cheng C et al.. 2022. Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth.. Nat Metab 4(5):575-588 PMID: 35534729
- 5. Dang EV et al.. 2017. Oxysterol Restraint of Cholesterol Synthesis Prevents AIM2 Inflammasome Activation.. Cell 171(5):1057-1071.e11 PMID: 29033131
- 6. Chu TT et al.. 2021. Tonic prime-boost of STING signalling mediates Niemann-Pick disease type C.. Nature 596(7873):570-575 PMID: 34290407
- 7. Wang S et al.. 2025. Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and AD.. Mol Neurodegener 20(1):15 PMID: 39901180
- 8. Li J et al.. 2026. Regulation of STING activation by phosphoinositide and cholesterol.. Nature 652(8109):499-507 PMID: 41639452
